author-photo

Kathrin Heinrich

Ludwig Maximilian University of Munich

20

Papers

25

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Consensus molecular subtypes and RAS status as biomarker of treatment intensity with fluoropyrimidine, bevacizumab, and irinotecan in metastatic colorectal cancer (XELAVIRI, AIO KRK 0110).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (1)
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3)

2021 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases: The PARLIM trial (AIO KRK 0314).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
OncoAlert Round Table Discussions: The Global COVID-19 Experience.

2021
Show All
- Source
- Cite
- Save
Citations (2)
FIRE-7-Studie (AIO-KRK-0120): Virtuelle, zentrale, interdisziplinäre Tumorkonferenz zur Verbesserung der sekundären Interventionsrate in mKRK-Patienten mit RAS-Mutation unter Therapie mit FOLFOXIRI und Bevacizumab

2021 The Forum
Show All
- Source
- Cite
- Save
Citations (0)
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).

2021 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials

2020 Journal of Cancer Research and Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306.

2020 Annals of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (7)